MXCT
Maxcyte
$1.71
+$0.17 (+11.04%)Oct 28, 2026
Key metrics
The numbers that frame MXCT today
- Market cap
- $176.48M
- Gross margin
- 79.2%
- EV / Sales
- 5.8
- ROIC
- -19.1%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $0.64
- 52wk High
- $1.81
Growth
Revenue and earnings trend for MXCT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about MXCT
Is Maxcyte a good buy?
Hold. Maxcyte has mixed quality and excellent momentum. The setup is mixed. Growth looks poor. That could put pressure on the long-term business case. We think Maxcyte is selling at a very high price.
What is the market capitalization of MXCT?
Maxcyte's market capitalization is $176.48M.
What is the 52-week high for MXCT stock?
The 52-week high for Maxcyte is $1.81. The current close of $1.71 is 5.3% below that high.
What is the 52-week low for MXCT stock?
The 52-week low for Maxcyte is $0.64. The current close of $1.71 is 165.9% above that low.
Does MXCT stock pay dividends?
Maxcyte does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for MXCT?
Maxcyte's Debt / Equity ratio is 0.11.